Dusseldorf - Delayed Quote EUR
Trulieve Cannabis Corp (T0A.DU)
3.8160
-0.1120
(-2.85%)
As of 8:11:50 AM GMT+2. Market Open.
Loading Chart for T0A.DU
- Previous Close
3.9280 - Open
3.8160 - Bid 3.8260 x --
- Ask 3.9500 x --
- Day's Range
3.8160 - 3.8160 - 52 Week Range
2.7720 - 12.3900 - Volume
0 - Avg. Volume
51 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: T0A.DU
View MorePerformance Overview: T0A.DU
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
T0A.DU
14.67%
S&P/TSX Composite index (^GSPTSE)
2.99%
1-Year Return
T0A.DU
63.31%
S&P/TSX Composite index (^GSPTSE)
13.67%
3-Year Return
T0A.DU
71.38%
S&P/TSX Composite index (^GSPTSE)
28.73%
5-Year Return
T0A.DU
82.37%
S&P/TSX Composite index (^GSPTSE)
70.40%
Compare To: T0A.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
3.8160
-2.85%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.2650
+0.83%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.2650
+0.95%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.0250
+0.99%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.6000
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.6100
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2360
0.00%
Mkt Cap EUR 76.786M
Industry Drug Manufacturers—Specialty & Generic
4.3150
+3.23%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0040
0.00%
Mkt Cap EUR 2.501M
Industry Drug Manufacturers—Specialty & Generic
4.3200
+3.10%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0540
-10.00%
Mkt Cap EUR 10.465M
Industry Drug Manufacturers—Specialty & Generic
Statistics: T0A.DU
View MoreValuation Measures
As of 5/9/2025
Market Cap
740.98M
Enterprise Value
1.18B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.71
Price/Book (mrq)
0.68
Enterprise Value/Revenue
1.12
Enterprise Value/EBITDA
4.83
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--